B20 - Human immunodeficiency virus [HIV] disease—190.23B
B97.35 - Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere—190.23B
C25 - Malignant neoplasm of pancreas—190.23B
C74 - Malignant neoplasm of adrenal gland—190.23B
C74.0 - Malignant neoplasm of cortex of adrenal gland—190.23B
C74.00 - Malignant neoplasm of cortex of unspecified adrenal gland—190.23B
C74.01 - Malignant neoplasm of cortex of right adrenal gland—190.23B
C74.02 - Malignant neoplasm of cortex of left adrenal gland—190.23B
C74.1 - Malignant neoplasm of medulla of adrenal gland—190.23B
C74.10 - Malignant neoplasm of medulla of unspecified adrenal gland—190.23B
C74.11 - Malignant neoplasm of medulla of right adrenal gland—190.23B
C74.12 - Malignant neoplasm of medulla of left adrenal gland—190.23B
C74.9 - Malignant neoplasm of unspecified part of adrenal gland—190.23B
C74.90 - Malignant neoplasm of unspecified part of unspecified adrenal gland—190.23B
C74.91 - Malignant neoplasm of unspecified part of right adrenal gland—190.23B
C74.92 - Malignant neoplasm of unspecified part of left adrenal gland—190.23B
C79.70 - Secondary malignant neoplasm of unspecified adrenal gland—190.23B
C79.71 - Secondary malignant neoplasm of right adrenal gland—190.23B
C79.72 - Secondary malignant neoplasm of left adrenal gland—190.23B
D13 - Benign neoplasm of other and ill-defined parts of digestive system—190.23B
D13.6 - Benign neoplasm of pancreas—190.23B
D35 - Benign neoplasm of other and unspecified endocrine glands—190.23B
D35.0 - Benign neoplasm of adrenal gland—190.23B
D35.00 - Benign neoplasm of unspecified adrenal gland—190.23B
D3A - Benign neuroendocrine tumors—190.23B
D3A.8 - Other benign neuroendocrine tumors—190.23B
D49 - Neoplasms of unspecified behavior—190.23B
D49.7 - Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system—190.23B
D63 - Anemia in chronic diseases classified elsewhere—190.23B
D63.1 - Anemia in chronic kidney disease—190.23B
D68.9 - Coagulation defect, unspecified—190.23B
E00 - Congenital iodine-deficiency syndrome—190.23B
E00.9 - Congenital iodine-deficiency syndrome, unspecified—190.23B
E01 - Iodine-deficiency related thyroid disorders and allied conditions—190.23B
E01.0 - Iodine-deficiency related diffuse (endemic) goiter—190.23B
E02 - Subclinical iodine-deficiency hypothyroidism—190.23B
E03 - Other hypothyroidism—190.23B
E03.0 - Congenital hypothyroidism with diffuse goiter—190.23B
E03.1 - Congenital hypothyroidism without goiter—190.23B
E03.2 - Hypothyroidism due to medicaments and other exogenous substances—190.23B
E03.3 - Postinfectious hypothyroidism—190.23B
E03.8 - Other specified hypothyroidism—190.23B
E03.9 - Hypothyroidism, unspecified—190.23B
E04 - Other nontoxic goiter—190.23B
E04.2 - Nontoxic multinodular goiter—190.23B
E04.9 - Nontoxic goiter, unspecified—190.23B
E05 - Thyrotoxicosis [hyperthyroidism]—190.23B
E05.0 - Thyrotoxicosis with diffuse goiter—190.23B
E05.1 - Thyrotoxicosis with toxic single thyroid nodule—190.23B
E05.8 - Other thyrotoxicosis—190.23B
E05.9 - Thyrotoxicosis, unspecified—190.23B
E06 - Thyroiditis—190.23B
E06.0 - Acute thyroiditis—190.23B
E06.1 - Subacute thyroiditis—190.23B
E06.2 - Chronic thyroiditis with transient thyrotoxicosis—190.23B
E06.3 - Autoimmune thyroiditis—190.23B
E06.4 - Drug-induced thyroiditis—190.23B
E06.5 - Other chronic thyroiditis—190.23B
E06.9 - Thyroiditis, unspecified—190.23B
E08 - Diabetes mellitus due to underlying condition—190.23B
E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy—190.23B
E08.69 - Diabetes mellitus due to underlying condition with other specified complication—190.23B
E08.8 - Diabetes mellitus due to underlying condition with unspecified complications—190.23B
E08.9 - Diabetes mellitus due to underlying condition without complications—190.23B
E09 - Drug or chemical induced diabetes mellitus—190.23B
E10 - Type 1 diabetes mellitus—190.23B
E10.1 - Type 1 diabetes mellitus with ketoacidosis—190.23B
E10.40 - Type 1 diabetes mellitus with diabetic neuropathy, unspecified—190.23B
E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy—190.23B
E10.42 - Type 1 diabetes mellitus with diabetic polyneuropathy—190.23B
E10.43 - Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy—190.23B
E10.8 - Type 1 diabetes mellitus with unspecified complications—190.23B
E10.9 - Type 1 diabetes mellitus without complications—190.23B
E11 - Type 2 diabetes mellitus—190.23B
E11.69 - Type 2 diabetes mellitus with other specified complication—190.23B
E11.8 - Type 2 diabetes mellitus with unspecified complications—190.23B
E11.9 - Type 2 diabetes mellitus without complications—190.23B
E13 - Other specified diabetes mellitus—190.23B
E13.2 - Other specified diabetes mellitus with kidney complications—190.23B
E13.21 - Other specified diabetes mellitus with diabetic nephropathy—190.23B
E13.22 - Other specified diabetes mellitus with diabetic chronic kidney disease—190.23B
E13.29 - Other specified diabetes mellitus with other diabetic kidney complication—190.23B
E13.9 - Other specified diabetes mellitus without complications—190.23B
E22 - Hyperfunction of pituitary gland—190.23B
E22.0 - Acromegaly and pituitary gigantism—190.23B
E22.8 - Other hyperfunction of pituitary gland—190.23B
E22.9 - Hyperfunction of pituitary gland, unspecified—190.23B
E26 - Hyperaldosteronism—190.23B
E26.1 - Secondary hyperaldosteronism—190.23B
E26.8 - Other hyperaldosteronism—190.23B
E26.9 - Hyperaldosteronism, unspecified—190.23B
E27 - Other disorders of adrenal gland—190.23B
E27.5 - Adrenomedullary hyperfunction—190.23B
E28 - Ovarian dysfunction—190.23B
E28.0 - Estrogen excess—190.23B
E28.2 - Polycystic ovarian syndrome—190.23B
E28.31 - Premature menopause—190.23B
E28.310 - Symptomatic premature menopause—190.23B
E34.4 - Constitutional tall stature—190.23B
E41 - Nutritional marasmus—190.23B
E43 - Unspecified severe protein-calorie malnutrition—190.23B
E44 - Protein-calorie malnutrition of moderate and mild degree—190.23B
E44.0 - Moderate protein-calorie malnutrition—190.23B
E44.1 - Mild protein-calorie malnutrition—190.23B
E45 - Retarded development following protein-calorie malnutrition—190.23B
E46 - Unspecified protein-calorie malnutrition—190.23B
E61 - Deficiency of other nutrient elements—190.23B
E65 - Localized adiposity—190.23B
E66 - Overweight and obesity—190.23B
E66.0 - Obesity due to excess calories—190.23B
E66.09 - Other obesity due to excess calories—190.23B
E66.3 - Overweight—190.23B
E66.8 - Other obesity—190.23B
E66.9 - Obesity, unspecified—190.23B
E70 - Disorders of aromatic amino-acid metabolism—190.23B
E71 - Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism—190.23B
E71.30 - Disorder of fatty-acid metabolism, unspecified—190.23B
E71.31 - Disorders of fatty-acid oxidation—190.23B
E71.310 - Long chain/very long chain acyl CoA dehydrogenase deficiency—190.23B
E71.311 - Medium chain acyl CoA dehydrogenase deficiency—190.23B
E71.312 - Short chain acyl CoA dehydrogenase deficiency—190.23B
E71.5 - Peroxisomal disorders—190.23B
E71.50 - Peroxisomal disorder, unspecified—190.23B
E71.522 - Adrenomyeloneuropathy—190.23B
E72 - Other disorders of amino-acid metabolism—190.23B
E72.11 - Homocystinuria—190.23B
E72.9 - Disorder of amino-acid metabolism, unspecified—190.23B
E74 - Other disorders of carbohydrate metabolism—190.23B
E74.0 - Glycogen storage disease—190.23B
E74.00 - Glycogen storage disease, unspecified—190.23B
E74.01 - von Gierke disease—190.23B
E74.02 - Pompe disease—190.23B
E74.09 - Other glycogen storage disease—190.23B
E75 - Disorders of sphingolipid metabolism and other lipid storage disorders—190.23B
E75.0 - GM2 gangliosidosis—190.23B
E75.00 - GM2 gangliosidosis, unspecified—190.23B
E75.02 - Tay-Sachs disease—190.23B
E75.2 - Other sphingolipidosis—190.23B
E75.21 - Fabry (-Anderson) disease—190.23B
E75.24 - Niemann-Pick disease—190.23B
E75.240 - Niemann-Pick disease type A—190.23B
E75.241 - Niemann-Pick disease type B—190.23B
E75.242 - Niemann-Pick disease type C—190.23B
E75.243 - Niemann-Pick disease type D—190.23B
E75.244 - —190.23B
E75.248 - Other Niemann-Pick disease—190.23B
E75.249 - Niemann-Pick disease, unspecified—190.23B
E75.26 - Sulfatase deficiency—190.23B
E75.29 - Other sphingolipidosis—190.23B
E75.3 - Sphingolipidosis, unspecified—190.23B
E75.5 - Other lipid storage disorders—190.23B
E75.6 - Lipid storage disorder, unspecified—190.23B
E77 - Disorders of glycoprotein metabolism—190.23B
E77.0 - Defects in post-translational modification of lysosomal enzymes—190.23B
E78 - Disorders of lipoprotein metabolism and other lipidemias—190.23B
E78.0 - Pure hypercholesterolemia—190.23B
E78.00 - Pure hypercholesterolemia, unspecified—190.23B
E78.01 - Familial hypercholesterolemia—190.23B
E78.1 - Pure hyperglyceridemia—190.23B
E78.2 - Mixed hyperlipidemia—190.23B
E78.4 - Other hyperlipidemia—190.23B
E78.5 - Hyperlipidemia, unspecified—190.23B
E78.6 - Lipoprotein deficiency—190.23B
E78.8 - Other disorders of lipoprotein metabolism—190.23B
E78.89 - Other lipoprotein metabolism disorders—190.23B
E78.9 - Disorder of lipoprotein metabolism, unspecified—190.23B
E83 - Disorders of mineral metabolism—190.23B
E83.11 - Hemochromatosis—190.23B
E83.110 - Hereditary hemochromatosis—190.23B
E83.111 - Hemochromatosis due to repeated red blood cell transfusions—190.23B
E83.118 - Other hemochromatosis—190.23B
E83.119 - Hemochromatosis, unspecified—190.23B
E85 - Amyloidosis—190.23B
E85.3 - Secondary systemic amyloidosis—190.23B
E85.4 - Organ-limited amyloidosis—190.23B
E85.8 - Other amyloidosis—190.23B
E85.9 - Amyloidosis, unspecified—190.23B
E87 - Other disorders of fluid, electrolyte and acid-base balance—190.23B
E87.1 - Hypo-osmolality and hyponatremia—190.23B
E88 - Other and unspecified metabolic disorders—190.23B
E88.01 - Alpha-1-antitrypsin deficiency—190.23B
E88.81 - Metabolic syndrome—190.23B
E88.9 - Metabolic disorder, unspecified—190.23B
E89 - Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified—190.23B
E89.0 - Postprocedural hypothyroidism—190.23B
F06.4 - Anxiety disorder due to known physiological condition—190.23B
F17 - Nicotine dependence—190.23B
F40 - Phobic anxiety disorders—190.23B
F40.0 - Agoraphobia—190.23B
F40.240 - Claustrophobia—190.23B
F40.8 - Other phobic anxiety disorders—190.23B
F41 - Other anxiety disorders—190.23B
F41.1 - Generalized anxiety disorder—190.23B
F41.3 - Other mixed anxiety disorders—190.23B
F41.9 - Anxiety disorder, unspecified—190.23B
F43 - Reaction to severe stress, and adjustment disorders—190.23B
F43.1 - Post-traumatic stress disorder (PTSD)—190.23B
F43.10 - Post-traumatic stress disorder, unspecified—190.23B
F43.11 - Post-traumatic stress disorder, acute—190.23B
F43.12 - Post-traumatic stress disorder, chronic—190.23B
F98 - Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence—190.23B
G08 - Intracranial and intraspinal phlebitis and thrombophlebitis—190.23B
G11 - Hereditary ataxia—190.23B
G11.1 - Early-onset cerebellar ataxia—190.23B
G11.2 - Late-onset cerebellar ataxia—190.23B
G45 - Transient cerebral ischemic attacks and related syndromes—190.23B
G45.1 - Carotid artery syndrome (hemispheric)—190.23B
G45.3 - Amaurosis fugax—190.23B
G45.9 - Transient cerebral ischemic attack, unspecified—190.23B
G46 - Vascular syndromes of brain in cerebrovascular diseases—190.23B
G46.4 - Cerebellar stroke syndrome—190.23B
G58 - Other mononeuropathies—190.23B
G58.9 - Mononeuropathy, unspecified—190.23B
G60 - Hereditary and idiopathic neuropathy—190.23B
G60.0 - Hereditary motor and sensory neuropathy—190.23B
G60.3 - Idiopathic progressive neuropathy—190.23B
G60.8 - Other hereditary and idiopathic neuropathies—190.23B
G61 - Inflammatory polyneuropathy—190.23B
G61.1 - Serum neuropathy—190.23B
G62 - Other and unspecified polyneuropathies—190.23B
G63 - Polyneuropathy in diseases classified elsewhere—190.23B
G89 - Pain, not elsewhere classified—190.23B
G89.29 - Other chronic pain—190.23B
G89.3 - Neoplasm related pain (acute) (chronic)—190.23B
G89.4 - Chronic pain syndrome—190.23B
G90.0 - Idiopathic peripheral autonomic neuropathy—190.23B
G90.09 - Other idiopathic peripheral autonomic neuropathy—190.23B
G99 - Other disorders of nervous system in diseases classified elsewhere—190.23B
I01 - Rheumatic fever with heart involvement—190.23B
I01.9 - Acute rheumatic heart disease, unspecified—190.23B
I10 - Essential (primary) hypertension—190.23B
I11 - Hypertensive heart disease—190.23B
I11.0 - Hypertensive heart disease with heart failure—190.23B
I11.9 - Hypertensive heart disease without heart failure—190.23B
I12 - Hypertensive chronic kidney disease—190.23B
I13 - Hypertensive heart and chronic kidney disease—190.23B
I15 - Secondary hypertension—190.23B
I15.2 - Hypertension secondary to endocrine disorders—190.23B
I15.8 - Other secondary hypertension—190.23B
I15.9 - Secondary hypertension, unspecified—190.23B
I16 - Hypertensive crisis—190.23B
I20 - Angina pectoris—190.23B
I20.0 - Unstable angina—190.23B
I20.1 - Angina pectoris with documented spasm—190.23B
I20.8 - Other forms of angina pectoris—190.23B
I20.9 - Angina pectoris, unspecified—190.23B
I21 - Acute myocardial infarction—190.23B
I21.0 - ST elevation (STEMI) myocardial infarction of anterior wall—190.23B
I21.1 - ST elevation (STEMI) myocardial infarction of inferior wall—190.23B
I21.2 - ST elevation (STEMI) myocardial infarction of other sites—190.23B
I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site—190.23B
I21.4 - Non-ST elevation (NSTEMI) myocardial infarction—190.23B
I22 - Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction—190.23B
I22.2 - Subsequent non-ST elevation (NSTEMI) myocardial infarction—190.23B
I23 - Certain current complications following ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction (within the 28 day period)—190.23B
I23.7 - Postinfarction angina—190.23B
I23.8 - Other current complications following acute myocardial infarction—190.23B
I24 - Other acute ischemic heart diseases—190.23B
I24.0 - Acute coronary thrombosis not resulting in myocardial infarction—190.23B
I24.8 - Other forms of acute ischemic heart disease—190.23B
I24.89 - —190.23B
I24.9 - Acute ischemic heart disease, unspecified—190.23B
I25 - Chronic ischemic heart disease—190.23B
I25.1 - Atherosclerotic heart disease of native coronary artery—190.23B
I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris—190.23B
I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris—190.23B
I25.2 - Old myocardial infarction—190.23B
I25.3 - Aneurysm of heart—190.23B
I25.41 - Coronary artery aneurysm—190.23B
I25.42 - Coronary artery dissection—190.23B
I25.5 - Ischemic cardiomyopathy—190.23B
I25.7 - Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris—190.23B
I25.8 - Other forms of chronic ischemic heart disease—190.23B
I25.9 - Chronic ischemic heart disease, unspecified—190.23B
I34 - Nonrheumatic mitral valve disorders—190.23B
I35 - Nonrheumatic aortic valve disorders—190.23B
I41 - Myocarditis in diseases classified elsewhere—190.23B
I42 - Cardiomyopathy—190.23B
I42.0 - Dilated cardiomyopathy—190.23B
I42.8 - Other cardiomyopathies—190.23B
I42.9 - Cardiomyopathy, unspecified—190.23B
I43 - Cardiomyopathy in diseases classified elsewhere—190.23B
I48 - Atrial fibrillation and flutter—190.23B
I48.0 - Paroxysmal atrial fibrillation—190.23B
I48.1 - Persistent atrial fibrillation—190.23B
I48.2 - Chronic atrial fibrillation—190.23B
I48.9 - Unspecified atrial fibrillation and atrial flutter—190.23B
I48.91 - Unspecified atrial fibrillation—190.23B
I49 - Other cardiac arrhythmias—190.23B
I49.0 - Ventricular fibrillation and flutter—190.23B
I49.8 - Other specified cardiac arrhythmias—190.23B
I49.9 - Cardiac arrhythmia, unspecified—190.23B
I50 - Heart failure—190.23B
I50.20 - Unspecified systolic (congestive) heart failure—190.23B
I50.21 - Acute systolic (congestive) heart failure—190.23B
I50.22 - Chronic systolic (congestive) heart failure—190.23B
I50.23 - Acute on chronic systolic (congestive) heart failure—190.23B
I50.30 - Unspecified diastolic (congestive) heart failure—190.23B
I50.31 - Acute diastolic (congestive) heart failure—190.23B
I50.32 - Chronic diastolic (congestive) heart failure—190.23B
I50.33 - Acute on chronic diastolic (congestive) heart failure—190.23B
I50.40 - Unspecified combined systolic (congestive) and diastolic (congestive) heart failure—190.23B
I50.41 - Acute combined systolic (congestive) and diastolic (congestive) heart failure—190.23B
I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure—190.23B
I50.43 - Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure—190.23B
I50.9 - Heart failure, unspecified—190.23B
I51 - Complications and ill-defined descriptions of heart disease—190.23B
I51.7 - Cardiomegaly—190.23B
I51.9 - Heart disease, unspecified—190.23B
I52 - Other heart disorders in diseases classified elsewhere—190.23B
I5A - —190.23B
I61 - Nontraumatic intracerebral hemorrhage—190.23B
I61.9 - Nontraumatic intracerebral hemorrhage, unspecified—190.23B
I62 - Other and unspecified nontraumatic intracranial hemorrhage—190.23B
I62.0 - Nontraumatic subdural hemorrhage—190.23B
I63 - Cerebral infarction—190.23B
I63.0 - Cerebral infarction due to thrombosis of precerebral arteries—190.23B
I63.00 - Cerebral infarction due to thrombosis of unspecified precerebral artery—190.23B
I63.8 - Other cerebral infarction—190.23B
I63.9 - Cerebral infarction, unspecified—190.23B
I65 - Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction—190.23B
I65.21 - Occlusion and stenosis of right carotid artery—190.23B
I65.22 - Occlusion and stenosis of left carotid artery—190.23B
I65.23 - Occlusion and stenosis of bilateral carotid arteries—190.23B
I65.29 - Occlusion and stenosis of unspecified carotid artery—190.23B
I66 - Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction—190.23B
I66.3 - Occlusion and stenosis of cerebellar arteries—190.23B
I66.9 - Occlusion and stenosis of unspecified cerebral artery—190.23B
I67 - Other cerebrovascular diseases—190.23B
I67.1 - Cerebral aneurysm, nonruptured—190.23B
I67.2 - Cerebral atherosclerosis—190.23B
I67.82 - Cerebral ischemia—190.23B
I68.0 - Cerebral amyloid angiopathy—190.23B
I69 - Sequelae of cerebrovascular disease—190.23B
I69.0 - Sequelae of nontraumatic subarachnoid hemorrhage—190.23B
I69.00 - Unspecified sequelae of nontraumatic subarachnoid hemorrhage—190.23B
I69.093 - Ataxia following nontraumatic subarachnoid hemorrhage—190.23B
I70 - Atherosclerosis—190.23B
I70.0 - Atherosclerosis of aorta—190.23B
I70.91 - Generalized atherosclerosis—190.23B
I71 - Aortic aneurysm and dissection—190.23B
I71.02 - Dissection of abdominal aorta—190.23B
I71.13 - —190.23B
I71.23 - —190.23B
I71.3 - Abdominal aortic aneurysm, ruptured—190.23B
I71.30 - —190.23B
I71.31 - —190.23B
I71.32 - —190.23B
I71.33 - —190.23B
I71.4 - Abdominal aortic aneurysm, without rupture—190.23B
I71.40 - —190.23B
I72 - Other aneurysm—190.23B
I72.0 - Aneurysm of carotid artery—190.23B
I72.9 - Aneurysm of unspecified site—190.23B
I77 - Other disorders of arteries and arterioles—190.23B
I77.6 - Arteritis, unspecified—190.23B
I87 - Other disorders of veins—190.23B
I87.39 - Chronic venous hypertension (idiopathic) with other complications—190.23B
I95 - Hypotension—190.23B
I95.0 - Idiopathic hypotension—190.23B
I99 - Other and unspecified disorders of circulatory system—190.23B
K52 - Other and unspecified noninfective gastroenteritis and colitis—190.23B
K70 - Alcoholic liver disease—190.23B
K70.0 - Alcoholic fatty liver—190.23B
K70.1 - Alcoholic hepatitis—190.23B
K70.3 - Alcoholic cirrhosis of liver—190.23B
K70.30 - Alcoholic cirrhosis of liver without ascites—190.23B
K70.31 - Alcoholic cirrhosis of liver with ascites—190.23B
K70.4 - Alcoholic hepatic failure—190.23B
K71 - Toxic liver disease—190.23B
K71.3 - Toxic liver disease with chronic persistent hepatitis—190.23B
K71.7 - Toxic liver disease with fibrosis and cirrhosis of liver—190.23B
K72 - Hepatic failure, not elsewhere classified—190.23B
K72.00 - Acute and subacute hepatic failure without coma—190.23B
K72.01 - Acute and subacute hepatic failure with coma—190.23B
K72.11 - Chronic hepatic failure with coma—190.23B
K72.90 - Hepatic failure, unspecified without coma—190.23B
K72.91 - Hepatic failure, unspecified with coma—190.23B
K73 - Chronic hepatitis, not elsewhere classified—190.23B
K74 - Fibrosis and cirrhosis of liver—190.23B
K74.0 - Hepatic fibrosis—190.23B
K74.00 - Hepatic fibrosis, unspecified—190.23B
K74.01 - Hepatic fibrosis, early fibrosis—190.23B
K74.02 - Hepatic fibrosis, advanced fibrosis—190.23B
K74.2 - Hepatic fibrosis with hepatic sclerosis—190.23B
K74.3 - Primary biliary cirrhosis—190.23B
K74.4 - Secondary biliary cirrhosis—190.23B
K74.5 - Biliary cirrhosis, unspecified—190.23B
K74.6 - Other and unspecified cirrhosis of liver—190.23B
K74.60 - Unspecified cirrhosis of liver—190.23B
K74.69 - Other cirrhosis of liver—190.23B
K75 - Other inflammatory liver diseases—190.23B
K75.81 - Nonalcoholic steatohepatitis (NASH)—190.23B
K76 - Other diseases of liver—190.23B
K76.0 - Fatty (change of) liver, not elsewhere classified—190.23B
K76.1 - Chronic passive congestion of liver—190.23B
K76.2 - Central hemorrhagic necrosis of liver—190.23B
K76.8 - Other specified diseases of liver—190.23B
K76.89 - Other specified diseases of liver—190.23B
K76.9 - Liver disease, unspecified—190.23B
K80 - Cholelithiasis—190.23B
K80.0 - Calculus of gallbladder with acute cholecystitis—190.23B
K83 - Other diseases of biliary tract—190.23B
K83.1 - Obstruction of bile duct—190.23B
K85 - Acute pancreatitis—190.23B
K85.0 - Idiopathic acute pancreatitis—190.23B
K85.1 - Biliary acute pancreatitis—190.23B
K85.2 - Alcohol induced acute pancreatitis—190.23B
K85.20 - Alcohol induced acute pancreatitis without necrosis or infection—190.23B
K85.3 - Drug induced acute pancreatitis—190.23B
K85.8 - Other acute pancreatitis—190.23B
K85.9 - Acute pancreatitis, unspecified—190.23B
K86 - Other diseases of pancreas—190.23B
K86.0 - Alcohol-induced chronic pancreatitis—190.23B
K86.1 - Other chronic pancreatitis—190.23B
K86.8 - Other specified diseases of pancreas—190.23B
K86.9 - Disease of pancreas, unspecified—190.23B
K90 - Intestinal malabsorption—190.23B
K90.8 - Other intestinal malabsorption—190.23B
K90.89 - Other intestinal malabsorption—190.23B
K90.9 - Intestinal malabsorption, unspecified—190.23B
K91.1 - Postgastric surgery syndromes—190.23B
K91.2 - Postsurgical malabsorption, not elsewhere classified—190.23B
L12 - Pemphigoid—190.23B
L12.3 - Acquired epidermolysis bullosa—190.23B
L12.30 - Acquired epidermolysis bullosa, unspecified—190.23B
L12.9 - Pemphigoid, unspecified—190.23B
L83 - Acanthosis nigricans—190.23B
M05.5 - Rheumatoid polyneuropathy with rheumatoid arthritis—190.23B
M30 - Polyarteritis nodosa and related conditions—190.23B
M30.0 - Polyarteritis nodosa—190.23B
M30.1 - Polyarteritis with lung involvement [Churg-Strauss]—190.23B
M30.2 - Juvenile polyarteritis—190.23B
M30.3 - Mucocutaneous lymph node syndrome [Kawasaki]—190.23B
M30.8 - Other conditions related to polyarteritis nodosa—190.23B
M32 - Systemic lupus erythematosus (SLE)—190.23B
M32.1 - Systemic lupus erythematosus with organ or system involvement—190.23B
M32.10 - Systemic lupus erythematosus, organ or system involvement unspecified—190.23B
M33 - Dermatopolymyositis—190.23B
M33.0 - Juvenile dermatomyositis—190.23B
M33.1 - Other dermatomyositis—190.23B
M33.9 - Dermatopolymyositis, unspecified—190.23B
N00 - Acute nephritic syndrome—190.23B
N00.3 - Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis—190.23B
N00.9 - Acute nephritic syndrome with unspecified morphologic changes—190.23B
N01 - Rapidly progressive nephritic syndrome—190.23B
N01.2 - Rapidly progressive nephritic syndrome with diffuse membranous glomerulonephritis—190.23B
N02.2 - Recurrent and persistent hematuria with diffuse membranous glomerulonephritis—190.23B
N02.A - Recurrent and persistent hematuria with C3 glomerulonephritis—190.23B
N02.B3 - —190.23B
N03 - Chronic nephritic syndrome—190.23B
N03.0 - Chronic nephritic syndrome with minor glomerular abnormality—190.23B
N03.2 - Chronic nephritic syndrome with diffuse membranous glomerulonephritis—190.23B
N03.3 - Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis—190.23B
N03.4 - Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis—190.23B
N03.5 - Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis—190.23B
N03.7 - Chronic nephritic syndrome with diffuse crescentic glomerulonephritis—190.23B
N03.9 - Chronic nephritic syndrome with unspecified morphologic changes—190.23B
N03.A - Chronic nephritic syndrome with C3 glomerulonephritis—190.23B
N04 - Nephrotic syndrome—190.23B
N04.2 - Nephrotic syndrome with diffuse membranous glomerulonephritis—190.23B
N04.3 - Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis—190.23B
N04.8 - Nephrotic syndrome with other morphologic changes—190.23B
N04.9 - Nephrotic syndrome with unspecified morphologic changes—190.23B
N05 - Unspecified nephritic syndrome—190.23B
N05.0 - Unspecified nephritic syndrome with minor glomerular abnormality—190.23B
N05.2 - Unspecified nephritic syndrome with diffuse membranous glomerulonephritis—190.23B
N05.5 - Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis—190.23B
N08 - Glomerular disorders in diseases classified elsewhere—190.23B
N10 - Acute pyelonephritis—190.23B
N11.8 - Other chronic tubulo-interstitial nephritis—190.23B
N12 - Tubulo-interstitial nephritis, not specified as acute or chronic—190.23B
N13 - Obstructive and reflux uropathy—190.23B
N18 - Chronic kidney disease (CKD)—190.23B
N18.9 - Chronic kidney disease, unspecified—190.23B
N23 - Unspecified renal colic—190.23B
N26 - Unspecified contracted kidney—190.23B
N26.9 - Renal sclerosis, unspecified—190.23B
N28 - Other disorders of kidney and ureter, not elsewhere classified—190.23B
N28.1 - Cyst of kidney, acquired—190.23B
N83.20 - Unspecified ovarian cysts—190.23B
N95 - Menopausal and other perimenopausal disorders—190.23B
N95.0 - Postmenopausal bleeding—190.23B
N95.1 - Menopausal and female climacteric states—190.23B
N95.2 - Postmenopausal atrophic vaginitis—190.23B
N95.8 - Other specified menopausal and perimenopausal disorders—190.23B
N95.9 - Unspecified menopausal and perimenopausal disorder—190.23B
N97 - Female infertility—190.23B
N97.9 - Female infertility, unspecified—190.23B
N98.3 - Complications of attempted introduction of embryo in embryo transfer—190.23B
O09 - Supervision of high risk pregnancy—190.23B
O09.0 - Supervision of pregnancy with history of infertility—190.23B
O09.3 - Supervision of pregnancy with insufficient antenatal care—190.23B
O16 - Unspecified maternal hypertension—190.23B
O23.9 - Unspecified genitourinary tract infection in pregnancy—190.23B
O23.90 - Unspecified genitourinary tract infection in pregnancy, unspecified trimester—190.23B
O23.91 - Unspecified genitourinary tract infection in pregnancy, first trimester—190.23B
O23.92 - Unspecified genitourinary tract infection in pregnancy, second trimester—190.23B
O23.93 - Unspecified genitourinary tract infection in pregnancy, third trimester—190.23B
O24 - Diabetes mellitus in pregnancy, childbirth, and the puerperium—190.23B
O24.02 - Pre-existing type 1 diabetes mellitus, in childbirth—190.23B
O24.1 - Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium—190.23B
O24.4 - Gestational diabetes mellitus—190.23B
O24.41 - Gestational diabetes mellitus in pregnancy—190.23B
O26 - Maternal care for other conditions predominantly related to pregnancy—190.23B
O28 - Abnormal findings on antenatal screening of mother—190.23B
O28.9 - Unspecified abnormal findings on antenatal screening of mother—190.23B
O34.0 - Maternal care for congenital malformation of uterus—190.23B
O35 - Maternal care for known or suspected fetal abnormality and damage—190.23B
O35.0 - Maternal care for (suspected) central nervous system malformation in fetus—190.23B
O35.02 - —190.23B
O35.04 - —190.23B
O35.06 - —190.23B
O35.08 - —190.23B
O36.01 - Maternal care for anti-D [Rh] antibodies—190.23B
O86.2 - Urinary tract infection following delivery—190.23B
O90 - Complications of the puerperium, not elsewhere classified—190.23B
O90.5 - Postpartum thyroiditis—190.23B
O98 - Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium—190.23B
O98.71 - Human immunodeficiency virus [HIV] disease complicating pregnancy—190.23B
O99.01 - Anemia complicating pregnancy—190.23B
O99.280 - Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester—190.23B
O99.810 - Abnormal glucose complicating pregnancy—190.23B
O99.814 - Abnormal glucose complicating childbirth—190.23B
O99.830 - Other infection carrier state complicating pregnancy—190.23B
P04 - Newborn affected by noxious substances transmitted via placenta or breast milk—190.23B
P04.2 - Newborn affected by maternal use of tobacco—190.23B
P78.81 - Congenital cirrhosis (of liver)—190.23B
Q04 - Other congenital malformations of brain—190.23B
Q06 - Other congenital malformations of spinal cord—190.23B
Q07 - Other congenital malformations of nervous system—190.23B
Q10 - Congenital malformations of eyelid, lacrimal apparatus and orbit—190.23B
Q13 - Congenital malformations of anterior segment of eye—190.23B
Q14 - Congenital malformations of posterior segment of eye—190.23B
Q15 - Other congenital malformations of eye—190.23B
Q16 - Congenital malformations of ear causing impairment of hearing—190.23B
Q17 - Other congenital malformations of ear—190.23B
Q18 - Other congenital malformations of face and neck—190.23B
Q20 - Congenital malformations of cardiac chambers and connections—190.23B
Q21 - Congenital malformations of cardiac septa—190.23B
Q22 - Congenital malformations of pulmonary and tricuspid valves—190.23B
Q23 - Congenital malformations of aortic and mitral valves—190.23B
Q24 - Other congenital malformations of heart—190.23B
Q25 - Congenital malformations of great arteries—190.23B
Q26 - Congenital malformations of great veins—190.23B
Q27 - Other congenital malformations of peripheral vascular system—190.23B
Q28 - Other congenital malformations of circulatory system—190.23B
Q30 - Congenital malformations of nose—190.23B
Q31 - Congenital malformations of larynx—190.23B
Q32 - Congenital malformations of trachea and bronchus—190.23B
Q33 - Congenital malformations of lung—190.23B
Q34 - Other congenital malformations of respiratory system—190.23B
Q38 - Other congenital malformations of tongue, mouth and pharynx—190.23B
Q39 - Congenital malformations of esophagus—190.23B
Q40 - Other congenital malformations of upper alimentary tract—190.23B
Q43 - Other congenital malformations of intestine—190.23B
Q44 - Congenital malformations of gallbladder, bile ducts and liver—190.23B
Q45 - Other congenital malformations of digestive system—190.23B
Q50 - Congenital malformations of ovaries, fallopian tubes and broad ligaments—190.23B
Q51 - Congenital malformations of uterus and cervix—190.23B
Q52 - Other congenital malformations of female genitalia—190.23B
Q55 - Other congenital malformations of male genital organs—190.23B
Q61 - Cystic kidney disease—190.23B
Q61.02 - Congenital multiple renal cysts—190.23B
Q61.3 - Polycystic kidney, unspecified—190.23B
Q61.9 - Cystic kidney disease, unspecified—190.23B
Q62 - Congenital obstructive defects of renal pelvis and congenital malformations of ureter—190.23B
Q63 - Other congenital malformations of kidney—190.23B
Q64 - Other congenital malformations of urinary system—190.23B
Q74 - Other congenital malformations of limb(s)—190.23B
Q75 - Other congenital malformations of skull and face bones—190.23B
Q76 - Congenital malformations of spine and bony thorax—190.23B
Q79 - Congenital malformations of musculoskeletal system, not elsewhere classified—190.23B
Q81 - Epidermolysis bullosa—190.23B
Q81.9 - Epidermolysis bullosa, unspecified—190.23B
Q82 - Other congenital malformations of skin—190.23B
Q82.8 - Other specified congenital malformations of skin—190.23B
Q82.9 - Congenital malformation of skin, unspecified—190.23B
Q83 - Congenital malformations of breast—190.23B
Q84 - Other congenital malformations of integument—190.23B
Q86 - Congenital malformation syndromes due to known exogenous causes, not elsewhere classified—190.23B
Q87 - Other specified congenital malformation syndromes affecting multiple systems—190.23B
Q87.1 - Congenital malformation syndromes predominantly associated with short stature—190.23B
Q89 - Other congenital malformations, not elsewhere classified—190.23B
Q89.7 - Multiple congenital malformations, not elsewhere classified—190.23B
Q89.8 - Other specified congenital malformations—190.23B
Q89.9 - Congenital malformation, unspecified—190.23B
Q95 - Balanced rearrangements and structural markers, not elsewhere classified—190.23B
Q95.1 - Chromosome inversion in normal individual—190.23B
R00 - Abnormalities of heart beat—190.23B
R01 - Cardiac murmurs and other cardiac sounds—190.23B
R03 - Abnormal blood-pressure reading, without diagnosis—190.23B
R42 - Dizziness and giddiness—190.23B
R43.0 - Anosmia—190.23B
R54 - Age-related physical debility—190.23B
R73 - Elevated blood glucose level—190.23B
R74 - Abnormal serum enzyme levels—190.23B
R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH]—190.23B
R74.01 - Elevation of levels of liver transaminase levels—190.23B
R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV]—190.23B
R77 - Other abnormalities of plasma proteins—190.23B
R79 - Other abnormal findings of blood chemistry—190.23B
R79.1 - Abnormal coagulation profile—190.23B
R94 - Abnormal results of function studies—190.23B
R94.31 - Abnormal electrocardiogram [ECG] [EKG]—190.23B
R94.39 - Abnormal result of other cardiovascular function study—190.23B
R94.4 - Abnormal results of kidney function studies—190.23B
R94.5 - Abnormal results of liver function studies—190.23B
R94.6 - Abnormal results of thyroid function studies—190.23B
T45.615 - Adverse effect of thrombolytic drugs—190.23B
T45.615A - Adverse effect of thrombolytic drugs, initial encounter—190.23B
T45.615D - Adverse effect of thrombolytic drugs, subsequent encounter—190.23B
T45.615S - Adverse effect of thrombolytic drugs, sequela—190.23B
T82 - Complications of cardiac and vascular prosthetic devices, implants and grafts—190.23B
T82.855 - Stenosis of coronary artery stent—190.23B
T82.855A - Stenosis of coronary artery stent, initial encounter—190.23B
T82.855S - Stenosis of coronary artery stent, sequela—190.23B
T86 - Complications of transplanted organs and tissue—190.23B
T86.1 - Complications of kidney transplant—190.23B
T86.10 - Unspecified complication of kidney transplant—190.23B
T86.11 - Kidney transplant rejection—190.23B
T86.12 - Kidney transplant failure—190.23B
T86.19 - Other complication of kidney transplant—190.23B
T86.2 - Complications of heart transplant—190.23B
T86.21 - Heart transplant rejection—190.23B
T86.22 - Heart transplant failure—190.23B
T86.29 - Other complications of heart transplant—190.23B
T86.4 - Complications of liver transplant—190.23B
T86.40 - Unspecified complication of liver transplant—190.23B
T86.41 - Liver transplant rejection—190.23B
T86.42 - Liver transplant failure—190.23B
T86.43 - Liver transplant infection—190.23B
T86.49 - Other complications of liver transplant—190.23B
Z00 - Encounter for general examination without complaint, suspected or reported diagnosis—190.23B
Z00.0 - Encounter for general adult medical examination—190.23B
Z00.00 - Encounter for general adult medical examination without abnormal findings—190.23B
Z00.01 - Encounter for general adult medical examination with abnormal findings—190.23B
Z00.8 - Encounter for other general examination—190.23B
Z01.41 - Encounter for routine gynecological examination—190.23B
Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings—190.23B
Z01.810 - Encounter for preprocedural cardiovascular examination—190.23B
Z01.83 - Encounter for blood typing—190.23B
Z01.84 - Encounter for antibody response examination—190.23B
Z02 - Encounter for administrative examination—190.23B
Z04 - Encounter for examination and observation for other reasons—190.23B
Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission—190.23B
Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]—190.23B
Z11.5 - Encounter for screening for other viral diseases—190.23B
Z11.51 - Encounter for screening for human papillomavirus (HPV)—190.23B
Z12.10 - Encounter for screening for malignant neoplasm of intestinal tract, unspecified—190.23B
Z13 - Encounter for screening for other diseases and disorders—190.23B
Z13.1 - Encounter for screening for diabetes mellitus—190.23B
Z13.21 - Encounter for screening for nutritional disorder—190.23B
Z13.22 - Encounter for screening for metabolic disorder—190.23B
Z13.220 - Encounter for screening for lipoid disorders—190.23B
Z13.228 - Encounter for screening for other metabolic disorders—190.23B
Z13.40 - Encounter for screening for unspecified developmental delays—190.23B
Z13.41 - Encounter for autism screening—190.23B
Z13.42 - Encounter for screening for global developmental delays (milestones)—190.23B
Z13.49 - Encounter for screening for other developmental delays—190.23B
Z13.5 - Encounter for screening for eye and ear disorders—190.23B
Z13.6 - Encounter for screening for cardiovascular disorders—190.23B
Z13.7 - Encounter for screening for genetic and chromosomal anomalies—190.23B
Z13.71 - Encounter for nonprocreative screening for genetic disease carrier status—190.23B
Z14 - Genetic carrier—190.23B
Z16 - Resistance to antimicrobial drugs—190.23B
Z16.33 - Resistance to antiviral drug(s)—190.23B
Z20 - Contact with and (suspected) exposure to communicable diseases—190.23B
Z20.6 - Contact with and (suspected) exposure to human immunodeficiency virus [HIV]—190.23B
Z21 - Asymptomatic human immunodeficiency virus [HIV] infection status—190.23B
Z30.014 - Encounter for initial prescription of intrauterine contraceptive device—190.23B
Z30.8 - Encounter for other contraceptive management—190.23B
Z31.430 - Encounter of female for testing for genetic disease carrier status for procreative management—190.23B
Z31.440 - Encounter of male for testing for genetic disease carrier status for procreative management—190.23B
Z31.5 - Encounter for procreative genetic counseling—190.23B
Z31.81 - Encounter for male factor infertility in female patient—190.23B
Z32.0 - Encounter for pregnancy test—190.23B
Z33 - Pregnant state—190.23B
Z34 - Encounter for supervision of normal pregnancy—190.23B
Z34.0 - Encounter for supervision of normal first pregnancy—190.23B
Z34.00 - Encounter for supervision of normal first pregnancy, unspecified trimester—190.23B
Z34.8 - Encounter for supervision of other normal pregnancy—190.23B
Z34.9 - Encounter for supervision of normal pregnancy, unspecified—190.23B
Z34.90 - Encounter for supervision of normal pregnancy, unspecified, unspecified trimester—190.23B
Z36 - Encounter for antenatal screening of mother—190.23B
Z36.0 - Encounter for antenatal screening for chromosomal anomalies—190.23B
Z36.4 - Encounter for antenatal screening for fetal growth retardation—190.23B
Z36.8 - Encounter for other antenatal screening—190.23B
Z48.21 - Encounter for aftercare following heart transplant—190.23B
Z48.23 - Encounter for aftercare following liver transplant—190.23B
Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy—190.23B
Z67 - Blood type—190.23B
Z68 - Body mass index [BMI]—190.23B
Z71.7 - Human immunodeficiency virus [HIV] counseling—190.23B
Z72 - Problems related to lifestyle—190.23B
Z72.0 - Tobacco use—190.23B
Z77 - Other contact with and (suspected) exposures hazardous to health—190.23B
Z77.120 - Contact with and (suspected) exposure to mold (toxic)—190.23B
Z78.0 - Asymptomatic menopausal state—190.23B
Z79 - Long term (current) drug therapy—190.23B
Z79.0 - Long term (current) use of anticoagulants and antithrombotics/antiplatelets—190.23B
Z79.01 - Long term (current) use of anticoagulants—190.23B
Z79.02 - Long term (current) use of antithrombotics/antiplatelets—190.23B
Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID)—190.23B
Z79.4 - Long term (current) use of insulin—190.23B
Z79.84 - Long term (current) use of oral hypoglycemic drugs—190.23B
Z79.89 - Other long term (current) drug therapy—190.23B
Z79.899 - Other long term (current) drug therapy—190.23B
Z81.2 - Family history of tobacco abuse and dependence—190.23B
Z82.3 - Family history of stroke—190.23B
Z82.4 - Family history of ischemic heart disease and other diseases of the circulatory system—190.23B
Z82.49 - Family history of ischemic heart disease and other diseases of the circulatory system—190.23B
Z82.71 - Family history of polycystic kidney—190.23B
Z83.0 - Family history of human immunodeficiency virus [HIV] disease—190.23B
Z83.3 - Family history of diabetes mellitus—190.23B
Z83.42 - Family history of familial hypercholesterolemia—190.23B
Z83.43 - Family history of other disorder of lipoprotein metabolism and other lipidemias—190.23B
Z83.430 - Family history of elevated lipoprotein(a)—190.23B
Z83.49 - Family history of other endocrine, nutritional and metabolic diseases—190.23B
Z84 - Family history of other conditions—190.23B
Z84.81 - Family history of carrier of genetic disease—190.23B
Z85.85 - Personal history of malignant neoplasm of endocrine glands—190.23B
Z85.9 - Personal history of malignant neoplasm, unspecified—190.23B
Z86.69 - Personal history of other diseases of the nervous system and sense organs—190.23B
Z86.7 - Personal history of diseases of the circulatory system—190.23B
Z86.73 - Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits—190.23B
Z86.79 - Personal history of other diseases of the circulatory system—190.23B
Z87.798 - Personal history of other (corrected) congenital malformations—190.23B
Z87.891 - Personal history of nicotine dependence—190.23B
Z92.23 - Personal history of estrogen therapy—190.23B
Z94.0 - Kidney transplant status—190.23B
Z94.1 - Heart transplant status—190.23B
Z94.3 - Heart and lungs transplant status—190.23B
Z94.4 - Liver transplant status—190.23B
Z94.89 - Other transplanted organ and tissue status—190.23B
Z94.9 - Transplanted organ and tissue status, unspecified—190.23B
Z98.6 - Angioplasty status—190.23B
Z98.61 - Coronary angioplasty status—190.23B
Z98.62 - Peripheral vascular angioplasty status—190.23B